Brokerages Set PubMatic, Inc. (NASDAQ:PUBM) PT at $18.25
PubMatic, Inc. (NASDAQ:PUBM – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twelve research firms that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and ten have given a buy recommendation to the […]
Brokerages Set Xometry, Inc. (NASDAQ:XMTR) PT at $108.33
Xometry, Inc. (NASDAQ:XMTR – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve ratings firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, six have issued a buy rating and one has issued […]
Brokerages Set onsemi (NASDAQ:ON) PT at $96.44
Shares of onsemi (NASDAQ:ON – Get Free Report) have been given a consensus rating of “Moderate Buy” by the thirty ratings firms that are currently covering the stock, MarketBeat.com reports. Fifteen equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The average 1 […]
Brokerages Set JD.com, Inc. (NASDAQ:JD) PT at $35.83
JD.com, Inc. (NASDAQ:JD – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the fourteen ratings firms that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and nine have issued a buy recommendation on the […]
Brokerages Set Golar LNG Limited (NASDAQ:GLNG) PT at $63.00
Golar LNG Limited (NASDAQ:GLNG – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the seven analysts that are currently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has issued a strong buy recommendation on the […]
Brokerages Set NovoCure Limited (NASDAQ:NVCR) PT at $21.20
Shares of NovoCure Limited (NASDAQ:NVCR – Get Free Report) have been assigned a consensus recommendation of “Hold” from the seven brokerages that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and two have assigned a buy recommendation to […]
last updated on 13 Sep 07:57